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INTRODUCTION
Hemangiomas are benign slow growing vascular tu-
mors that may occur anywhere in the body including 
bone, VH, was first described by Virchow in 1867 
and characteristic radiological appearances were first 
noted by Perman in 19261. VH is the most commonly 
encountered tumor of the vertebral column2. This be-
nign vascular lesion has an estimated incidence of 10-
12% in the population, based on large autopsy series 
(in about 11% at general autopsy) and a large review 
of plain spine films3,4,5,6. The true incidence of verte-
bral hemangioma is unknown as the majority of them 
are asymptomatic and remain undiagnosed through-
out the life. They may be detected as incidental roent-
genographic findings or when they produce local pain 
and/or swelling and/or symptoms or signs of spinal 
cord compression. Only 0,9-1,2% of all vertebral 
hemangiomas are symptomatic7,8. Women are affected 
more often than men and young adults are more com-
monly symptomatic than the elderly9. Involvement 
of more than five vertebral bodies is extremely rare2. 
Hemangiomas may occur in the posterior elements, 
the vertebral body, or even in a circumferential pat-
tern involving all three columns. Significant paraspi-
nal tumor masses are occasionally seen9. Treatment of 
vertebral hemangioma is usually done to relieve sym-
toms. Treatment methods include radiotherapy, sur-
gery, embolization, intralesional injection of ethanol, 
and vertebroplasty with methyl methacrylate. In this 
report the case of a patient who received radiotherapy 
is analysed.
CASE REPORT
A 50-year old man with hemangioma in the 8th Tho-
racic vertebra was referred to our Department for ir-
radiation, in June 2011. MRI showed a paravertebral 
mass (Figure 1), the differential diagnosis of which 
could not exclude neoplastic or tubercular nature of 
the lesion. Open biopsy confirmed that this mass was 
neoplastic. Routine blood examination, abdominal 
ultrasonography, chest and whole spine X-ray, were 
conducted in the patient and did not reveal any other 
disorder. The clinical evaluated features were back 
pain, radiculopathy (±), myelopathy (±). There were 
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no neurological signs, sensory deficits and the patient 
was with normal bladder/bowel function and normal 
reflexes. Initially the patient was treated with embo-
lization, then with surgery and perioperative alcohol 
injection. As the treatments failed to reduce the clini-
cal symptoms he was referred to our department for 
radiotherapy. He received 3D-conformal radiation 
therapy to the involved vertebra (Thoracic 8) with one 
vertebra above (Thoracic 7) and one below (Thoracic 
9) (Figures 2, 3, 4). The dose given to the planning 
target volume (PTV) was 40 Gy I 20 fractions (2Gy/
Fr), over 4 weeks. Radiation was delivered by three 
fields. Oral Dexamethasone at a dose of 12mg daily 
in divided doses was started along with radiotherapy 
to minimize radiation induced edema and gradually 
tailored off at the end of radiation. Analgesics were 
given as required; physiotherapy was started at soon 
as patient’s condition permitted and continued even 
after completion of radiation. Muscle power was as-
sessed at the beginning of radiation, 4 weeks after 
completion and thereafter at three months interval 
during follow-up. At the end of therapy the patient 
had decreased pain and overall better physical status. 
The MRI 3 months after the end of irradiation therapy, 
showed reduction of the paravertebral mass at the lev-
el of the 8th thoracic vertebra (Figure 5). The patient 
did not develop backache and myelopathy. Analgesics 
were no more required two months after the comple-
tion of radiotherapy. 
DISCUSSION
Hemangiomas are benign slow growing vascular tu-
mors composed of newly formed capillary, cavernous 
or venous blood vessels. Among skeletal locations, 
vertebrae are the second commonest site and thoracic 
spine is affected most frequently10. At the present case, 
the vertebral hemangioma was of thoracic origin.
Vertebral hemangiomas are benign vascular le-
sions11. They can be of cavernous, capillary or mixed 
type2,9. In the cavernous form, dilated blood vessels 
get clustered without the intervention of bone stroma. 
In the capillary form, the walled blood vessels are sep-
arated by normal bone tissue. Arteriovenous shunting 
is not typically present9.
Several options are available for the management 
of symptomatic vertebral hemangiomas and multiple 
Figure 1. Paravertebral mass in Th8 (MRI before radiotherapy).
 The Efficasy of Radiotherapy in Vertebral Hemangiomas 31
Figure 2, 3, 4. CTV-clinical target volume (red) Treatment planning-fields. For 2D, 3D conformal radiotherapy.
2
3
4
32 Aristotle University Medical Journal, Vol. 40, Issue 1, February 2013
modalities may have to be used for a single patient. 
Among the treatment modalities, the non-surgical 
ones (such as endovascular embolization, injection of 
alcohol or methyl methacrylate into the vertebral body 
and radiation therapy) are preferred due to the highly 
vascular nature of the tumor, because of the threat of 
mortality due to exsanguinations, the difficulty in ap-
proaching and the complete excision of the tumor with 
its associated morbidity during surgery. The goals of 
surgery include bony decompression by laminectomy 
or vertebrectomy and excision of soft tissue compo-
nents of the tumor compressing the neural elements. 
Surgery can be correlated with embolization or injec-
tion of absolute alcohol.
Endovascular embolization with particulate agents 
such as polyvinyl alcohol foam is reported to produce 
dramatic but usually transient remissions of the le-
sion12,13,14. Recently, percutaneous injection of methyl 
methacrylate into the vertebral body has generated 
considerable interest21. Methyl methacrylate is an ide-
al agent to stabilize the vertebral bodies which are at 
risk of collapse. Leakage of the agent into the drain-
ing veins or posteriorly into the spinal canal may be 
hazardous. 
Even in a paraparetic patients, due to extension of 
the hemangioma into the spinal canal, methacrylate 
may fill the intra spinal compartment and may exacer-
bate the already existing cord compression, requiring 
immediate laminectomy. In addition, when laminae 
and pedicles are also involved by the hemangioma 
(which is a frequent feature in cord compression), 
the surgeon is in front of considerable intra operative 
bleeding during laminectomy. The injection of meth-
yl methacrylate into the vertebral body and N-butyl 
cyanocrylate into the laminae and pedicles are rec-
ommended, in order to overcome this complication. 
Methyl methacrylate strengthens the vertebral body 
to prevent pathological fracture and cyanocrylate re-
duces the intra operative bleeding during subsequent 
laminectomy22. 
Vertebral hemangiomas are radiosensitive lesions 
that respond to administration of 30 to 40 Gy15. Radia-
tion therapy has been used most often to treat lesions 
associated with pain. Different reports suggest that 
Figure 5. Reduction of paravertebral mass in Th8 (MRI after 3 months at the end of radiotherapy) follow-up.
 The Efficasy of Radiotherapy in Vertebral Hemangiomas 33
radiotherapy alone or in combination can give good 
symptomatic relief of pain16,17. The radiation therapy 
is also used in some patients, after decompression 
to avoid further deterioration. In cases of acute spi-
nal compression, radiation offers satisfying results of 
relief18,19. Young et al reported that five out of seven 
paraplegic patients recovered sufficiently to walk 
again, after external radiotherapy alone. Recovery 
was complete in three of them. They also concluded 
that radiation can be used as a primary treatment in 
patients with severe cord compression. Operative de-
compression can be employed in cases of failure of 
radiation therapy17.
The exact mechanism of action of radiotherapy 
on vertebral hemangiomas is not clearly known. On 
the other hand pain relief is seen in almost all patients 
treated with radiation. It may be supposed that re-
sponse to radiotherapy is similar to that seen in pain 
relief due to radiation in the management of vertebral 
metastasis. Radiotherapy can result in loss of seg-
ments of capillaries causing deficit of micro vascular 
network, with subsequent ischaemic changes. Anti-in-
flammatory effect of radiation has also been attributed 
for the relief of pain observed with radiotherapy20. In 
our case, the patient presented therapeutic response 
(pain relief and regression of hemangioma) after re-
ceiving a dose of 40Gy (2GyX20fraction in 4 wks). 
The radiation dose received in the target volume and 
fractionation schedule was similar to the schemes 
used by several investigators that suggest a total dose 
of 30 to 40 Gy (1,8 to 2Gy/fraction)16,17,18,24. Rades et 
al (2003) pooled and studied (LQ model-statistical 
analysis) the data to understand the impact of total 
dose on complete pain relief by using equivalent dose 
to 2Gy fractions25. It was concluded that 40Gy with 
2Gy/fraction gives sufficient pain relief. 
Malignant transformation of vertebral hemangio-
mas is virtually unknown26.
Malignant component was reported in a patient 
in whom repeated irradiation was given for recurrent 
hemangioma. The lesion had an aggressive behavior 
with repeated recurrences, which is not characteristic 
of benign hemangiomas. It was concluded that malig-
nancy is unlikely to be due to irradiation27. Up to date 
there is not much evidence of malignant transforma-
tion of the lesions, because of radiation therapy.
CONCLUSION
The aim of radiotherapy in hemangiomas is to elimi-
nate the abnormal veins and capillaries and to reduce 
the size of the lesion. A known long term effect of 
radiotherapy is impairment of circulation by causing 
vascular endothelial damage. Radiotherapy is an ef-
fective and acceptable mode of treatment for symp-
tomatic hemangiomas of vertebra, where pain is the 
main symptom. Other options exist, like intralessional 
injection of ethanol, vertebroplasty with methacrylate, 
surgical decompression etc. These options are inva-
sive techniques involving risks, where as radiotherapy 
in non-invasive and safe.
It is considered that 40Gy delivered by conven-
tional fractionation (2Gy/fraction) is the best dose at 
present. This is the accepted standard dose to achieve 
compensatory pain relief and at the same time is close 
to the tolerance level(TD5/5) of the spinal cord. How-
ever, in the present era of Intensity Modulated Radia-
tion Therapy(IMRT), higher doses of radiation may 
be delivered to the involved parts of the vertebrae and 
may yield improved results without any substantially 
increased risk of spinal cord damage, which would be 
evaluated by further clinical studies.
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